Biles' Final Stint Might Cost a Fortune

In partnership with

Hey Athletic Fans,

Ticket prices are already skyrocketing because if this really is Simone Biles' last shot at Olympic gold, nobody wants to miss being in the building for it. Elsewhere, in an exclusive sit-down, figure skating legend Tara Lipinski opens up about her daughter and the legacy she hopes to pass down.

Full stories waiting in tonight's evening edition of Essentially Athletics.

Skincare built by longevity scientists — not marketers

Most skincare addresses what happens after your skin ages: the appearance of wrinkles, loss of visible firmness, and dullness. But four PhD longevity scientists asked a different question: what if you could target the cellular process that causes visible aging in the first place?

Their answer is OS-01, the first peptide scientifically proven to address senescent cells — the damaged "zombie cells" that accumulate with age and accelerate visible skin decline. The result: the first topical clinically validated to address visible skin aging at the source. In a double-blind 12-week clinical study of OS-01 FACE:

• 100% of users showed improved overall appearance

• 96% improved visible firmness

• 87% showed improvement in the appearance of wrinkles

• Barrier strength improved 15%

This isn't skincare with better marketing. It's skincare with better science. And real results.

Get 15% off + free gifts

^{*Explore the claims at oneskin.co}